Janux Therapeutics, Inc. (JANX)
14.58
-0.04
(-0.27%)
USD |
NASDAQ |
May 07, 15:45
Janux Therapeutics SG&A Expense (TTM) : 41.77M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Bristol Myers Squibb Co. | 7.30B |
| EyePoint, Inc. | 37.79M |
| CorMedix, Inc. | 99.77M |
| ADMA Biologics, Inc. | 96.42M |
| Viking Therapeutics, Inc. | 48.28M |